Legal Representation
Attorney
Roman Fayerberg
USPTO Deadlines
Application History
25 events| Date | Code | Type | Description | Documents |
|---|---|---|---|---|
| Aug 7, 2023 | MAB6 | E | ABANDONMENT NOTICE E-MAILED - NO USE STATEMENT FILED | Loading... |
| Aug 7, 2023 | ABN6 | S | ABANDONMENT - NO USE STATEMENT FILED | Loading... |
| Dec 24, 2022 | EXRA | E | NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED | Loading... |
| Dec 22, 2022 | EX3G | S | SOU EXTENSION 3 GRANTED | Loading... |
| Dec 22, 2022 | EXT3 | S | SOU EXTENSION 3 FILED | Loading... |
| Dec 22, 2022 | EEXT | I | SOU TEAS EXTENSION RECEIVED | Loading... |
| Jul 8, 2022 | EXRA | E | NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED | Loading... |
| Jul 6, 2022 | EX2G | S | SOU EXTENSION 2 GRANTED | Loading... |
| Jul 6, 2022 | EXT2 | S | SOU EXTENSION 2 FILED | Loading... |
| Jul 6, 2022 | EEXT | I | SOU TEAS EXTENSION RECEIVED | Loading... |
| Jan 15, 2022 | EXRA | E | NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED | Loading... |
| Jan 14, 2022 | EX1G | S | SOU EXTENSION 1 GRANTED | Loading... |
| Jan 6, 2022 | EXT1 | S | SOU EXTENSION 1 FILED | Loading... |
| Jan 14, 2022 | AITU | A | CASE ASSIGNED TO INTENT TO USE PARALEGAL | Loading... |
| Jan 6, 2022 | EEXT | I | SOU TEAS EXTENSION RECEIVED | Loading... |
| Jan 6, 2022 | EPPA | I | TEAS POST PUBLICATION AMENDMENT RECEIVED | Loading... |
| Jul 6, 2021 | NOAM | E | NOA E-MAILED - SOU REQUIRED FROM APPLICANT | Loading... |
| May 11, 2021 | NPUB | E | OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED | Loading... |
| May 11, 2021 | PUBO | A | PUBLISHED FOR OPPOSITION | Loading... |
| Apr 21, 2021 | NONP | E | NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED | Loading... |
| Apr 6, 2021 | CNSA | P | APPROVED FOR PUB - PRINCIPAL REGISTER | Loading... |
| Mar 24, 2021 | DOCK | D | ASSIGNED TO EXAMINER | Loading... |
| Dec 12, 2020 | MDSC | E | NOTICE OF DESIGN SEARCH CODE E-MAILED | Loading... |
| Dec 11, 2020 | NWOS | I | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED | Loading... |
| Oct 27, 2020 | NWAP | I | NEW APPLICATION ENTERED | Loading... |
Detailed Classifications
Class 042
Research and development related to platelets, platelet variants, megakaryocytes, megakaryocytes variants, and products derived from platelets, megakaryocytes or their variants, including, extracellular vesicles or exosomes; Research and development in the field of allogeneic cell therapy, platelet variants, drug delivery and pharmaceutical compositions comprising platelet variants for the treatment of tumors, immune-oncology, hematology, cardiovascular, inflammatory, immune and autoimmune diseases, conditions, or responses, critical care disorders, conditions and injuries, solid organ transplantation, wound healing, neurological disorders, and orthopedics; Biotechnology research; Research in the field of allogeneic cell therapy, platelet variants and pharmaceutical compositions comprising platelet variants; Pharmaceutical research and development; Medical research; Scientific research; Medical and scientific research in the field of allogeneic cell therapy, platelet variants, and pharmaceutical compositions comprising platelet variants for the treatment of tumors, immune-oncology, hematology, cardiovascular, inflammatory, immune and autoimmune diseases, conditions, or responses, critical care disorders, conditions and injuries, solid organ transplantation, wound healing, neurological disorders, and orthopedics; Research and development related to viral vectors and delivery of viral vectors
Additional Information
Design Mark
The mark consists of a Pegasus design.
Classification
International Classes
042